SYBLEU INC (SYBE)
USD 0.06
(34.15%)
USD 0.06
(34.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -180.3 Thousand USD | 26.51% |
| 2021 | -245.34 Thousand USD | -140.9% |
| 2020 | -101.84 Thousand USD | -119.93% |
| 2019 | -46.3 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -29.03 Thousand USD | -56.71% |
| 2023 Q3 | -145.63 Thousand USD | -28.89% |
| 2023 Q4 | -20.22 Thousand USD | 86.12% |
| 2023 Q2 | -112.99 Thousand USD | -289.17% |
| 2022 Q3 | -19.75 Thousand USD | 0.0% |
| 2022 FY | -180.3 Thousand USD | 26.51% |
| 2022 Q4 | -18.52 Thousand USD | 6.19% |
| 2021 FY | -245.34 Thousand USD | -140.9% |
| 2020 FY | -101.84 Thousand USD | -119.93% |
| 2019 FY | -46.3 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 86.498% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 97.418% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 100.34% |
| Nascent Biotech, Inc. | -2.08 Million USD | 91.363% |
| Rebus Holdings, Inc. | -1.02 Million USD | 82.323% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 100.277% |
| Qrons Inc. | -789.34 Thousand USD | 77.158% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 71.489% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 99.712% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 56.603% |
| Skye Bioscience, Inc. | -37.64 Million USD | 99.521% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 99.759% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 97.258% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 34.052% |
| SQZ Biotechnologies Company | -79.46 Million USD | 99.773% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 93.766% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 90.096% |
| Mesoblast Limited | -87.95 Million USD | 99.795% |
| Marizyme, Inc. | -65.34 Million USD | 99.724% |
| Genus plc | 7.9 Million USD | 102.282% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 98.345% |
| Pharming Group N.V. | -10.54 Million USD | 98.291% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 91.69% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 95.14% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 97.961% |
| ContraFect Corporation | -65.15 Million USD | 99.723% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 96.31% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 89.562% |
| IMV Inc. | -36.48 Million USD | 99.506% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 97.763% |
| MultiCell Technologies, Inc. | -380.07 USD | -47339.682% |
| ONE Bio Corp. | 8.67 Million USD | 102.078% |
| Accustem Sciences Inc. | -3.74 Million USD | 95.187% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 99.651% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 85.771% |
| Q BioMed Inc. | -2.05 Million USD | 91.214% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 95.17% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 92.427% |
| Biomind Labs Inc. | -1.21 Million USD | 85.152% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 99.698% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 94.187% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 97.719% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 90.75% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -1103.953% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 98.864% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 96.901% |
| GB Sciences, Inc. | -1.36 Million USD | 86.759% |
| Alpha Cognition Inc. | -13.77 Million USD | 98.691% |
| HST Global, Inc. | -146.21 Thousand USD | -23.319% |
| CSL Limited | 2.64 Billion USD | 100.007% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 89.725% |
| Halberd Corporation | -79.67 Thousand USD | -126.297% |
| Enzolytics Inc. | -2.17 Million USD | 91.717% |
| Agentix Corp. | -1.37 Million USD | 86.879% |
| Resverlogix Corp. | -3.61 Million USD | 95.005% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 94.315% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.939% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 283.984% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 102.604% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 95.462% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 94.042% |
| AVAX Technologies, Inc. | -6.41 Million USD | 97.189% |
| Zenith Capital Corp. | -10.59 Million USD | 98.298% |
| Genscript Biotech Corporation | -95.47 Million USD | 99.811% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -675.768% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 95.651% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -198.316% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 91.008% |
| Kadimastem Ltd | -3.3 Million USD | 94.548% |
| Helix BioMedix, Inc. | -1.05 Million USD | 82.927% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 95.279% |
| BioStem Technologies, Inc. | -8.48 Million USD | 97.875% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 59.149% |
| LadRx Corporation | 400.44 Thousand USD | 145.026% |
| Cell Source, Inc. | -5.32 Million USD | 96.612% |
| Regen BioPharma, Inc. | 1.02 Million USD | 117.616% |
| Regen BioPharma, Inc. | 1.02 Million USD | 117.616% |
| NovAccess Global Inc. | -4.76 Million USD | 96.219% |
| Affymax, Inc. | -14.42 Million USD | 98.75% |
| Itoco Inc. | -1.86 Million USD | 90.353% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 95.941% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 89.197% |
| Mobile Lads Corp. | -2.26 Million USD | 92.034% |
| CytoDyn Inc. | -49.84 Million USD | 99.638% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -128.138% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 20.963% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 80.85% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 88.82% |
| International Stem Cell Corporation | -131 Thousand USD | -37.637% |
| Bioxytran, Inc. | -4.28 Million USD | 95.787% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -232.223% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 92.874% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 99.625% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 91.471% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 76.91% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 94.309% |
| Neutra Corp. | -233.46 Thousand USD | 22.77% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 99.111% |
| PureTech Health plc | -65.69 Million USD | 99.726% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 99.152% |
| IXICO plc | -1.17 Million USD | 84.694% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 98.184% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 99.684% |
| CSL Limited | 2.64 Billion USD | 100.007% |
| Cellectis S.A. | -103.17 Million USD | 99.825% |